Literature DB >> 23783994

[Contact lens associated dry eye. Current study results and practical implementation].

R Khaireddin1.   

Abstract

Contact lens-associated dry eye symptoms have mostly been therapeutically addressed using artificial tears containing hyaluronic acid to supplement tear film volume with often unsatisfactory results. However, the main reason for contact lens-associated dry eye is not the lack of tear fluid but the lack of tear film stability due to meibomian gland dysfunction leading to reduction of the lipid film of tears. This is associated with increased evaporation of the aqueous phase of tear fluid and a measurable hyperosmolarity of the residual "denatured" tear film. A subsequent inflammatory reaction of the ocular surface then leads to the vicious circle of dry eye. The aim of this review is to summarize current study results on this topic and to give practical advice on how to address dry eye symptoms in contact lens wearers more accurately. For most contact lens-associated dry eye symptoms a combined therapy with unpreserved artificial tears plus phospholipid-liposome eye spray yields the best results. In cases of additional signs of blepharitis the regular use of phospholipid-liposome solution for lid margin hygiene is beneficial.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23783994     DOI: 10.1007/s00347-013-2864-4

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  21 in total

1.  [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].

Authors:  S Lee; S Dausch; G Maierhofer; D Dausch
Journal:  Klin Monbl Augenheilkd       Date:  2004-10       Impact factor: 0.700

2.  The stability of dryness symptoms after refitting with silicone hydrogel contact lenses over 3 years.

Authors:  Jeffrey Schafer; G Lynn Mitchell; Robin L Chalmers; Bill Long; Sally Dillehay; Joseph Barr; Peter Bergenske; Peter Donshik; Glenda Secor; John Yoakum
Journal:  Eye Contact Lens       Date:  2007-09       Impact factor: 2.018

3.  Hydrogel lens dehydration and subjective comfort and dryness ratings in symptomatic and asymptomatic contact lens wearers.

Authors:  D Fonn; P Situ; T Simpson
Journal:  Optom Vis Sci       Date:  1999-10       Impact factor: 1.973

Review 4.  [Blepharitis].

Authors:  T Kaercher; H Brewitt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

5.  Evaluation of the clinical course of dry eye syndrome.

Authors:  Jutta Horwath-Winter; Andrea Berghold; Otto Schmut; Ingrid Floegel; Verena Solhdju; Elizabeth Bodner; Gerold Schwantzer; Eva-Maria Haller-Schober
Journal:  Arch Ophthalmol       Date:  2003-10

6.  [Diagnosis and and differentiation of dry eye disorders].

Authors:  A Heiligenhaus; J M Koch; F E Kruse; C Schwarz; T N Waubke
Journal:  Ophthalmologe       Date:  1995-02       Impact factor: 1.059

7.  [Eyelid hygiene for contact lens wearers with blepharitis. Comparative investigation of treatment with baby shampoo versus phospholipid solution].

Authors:  R Khaireddin; A Hueber
Journal:  Ophthalmologe       Date:  2013-02       Impact factor: 1.059

Review 8.  [Osmoprotection as a new therapeutic principle].

Authors:  E M Messmer
Journal:  Ophthalmologe       Date:  2007-11       Impact factor: 1.059

9.  Ocular surface changes and discomfort in patients with meibomian gland dysfunction.

Authors:  J Shimazaki; M Sakata; K Tsubota
Journal:  Arch Ophthalmol       Date:  1995-10

10.  Contact lens wear is associated with decrease of meibomian glands.

Authors:  Reiko Arita; Kouzo Itoh; Kenji Inoue; Aya Kuchiba; Takuhiro Yamaguchi; Shiro Amano
Journal:  Ophthalmology       Date:  2009-01-22       Impact factor: 12.079

View more
  1 in total

1.  Liposomal Eye Spray Is as Effective as Antihistamine Eye Drops in Patients with Allergic Rhinoconjunctivitis Induced by Conjunctival Provocation Testing.

Authors:  Anne-Nele Grzella; Sabine Schleicher; Kija Shah-Hosseini; Anatoli Astvatsatourov; Esther Raskopf; Silke Allekotte; Ralph Mösges
Journal:  Int Arch Allergy Immunol       Date:  2019-03-25       Impact factor: 2.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.